Advanced Therapies 2023

Presentation: Targeting of HLA-G positive tumors with cytotoxic immune cells engineered with a Chimeric ILT-Receptor
Poster Session: Engineered Natural Killer Cells Expressing Chimeric ILT Receptors (CIR) Effectively Target HLA-G-Positive AML Tumor Cells
Speaker: Raphaël G. Ognar, MSc, MBA (President & CEO, Co-founder NKILT Therapeutics)
Date: March 14, 2023
Time: 4:20 pm GMT

Poster: Targeting of HLA-G positive tumors with cytotoxic immune cells engineered with a Chimeric ILT-Receptor
Author: Simon Wain-Hobson, PhD (CSO, Co-founder NKILT Therapeutics)